Plunkett Research Online: Forward Pharma

FORWARD PHARMA (FWP:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Forward Pharma A/S is a biopharmaceutical company which engages in the research and production of a medicinal treatment for multiple sclerosis and psoriasis. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company is engaged in segments of the pharmaceutical an.....



Forward Pharma
Ticker: FWP
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 45 33444242
Fax:
Address: Ostergade 24A, 1st Floor
Copenhagen, 1100 Denmark

Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
ContactsDescription
Claus SvendsenCEO
Florian SchonhartingChairman of the Board/Director
See More
Forward Pharma A/S is a biopharmaceutical company which engages in the research and production of a medicinal treatment for multiple sclerosis and psoriasis. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company is engaged in segments of the pharmaceutical an.....See More See More

Auditor: Ernst & Young
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: